Tadas Trunca

Tadas Trunca is a notable leader in the biopharmaceutical and life sciences industry, currently holding the position of Senior Director of Product Management for the Nucleic Acids & Nanomedicine Business Unit at Cytiva. With a robust background in managing and developing cutting-edge products for gene therapies, Tadas has significantly contributed to advancements in nucleic acid therapeutics, including DNA/RNA oligonucleotides, mRNA, and lipid nanoparticles. His role encompasses overseeing product strategy, development, and market introduction, ensuring that innovative solutions reach the biopharmaceutical community. 

Tadas’s expertise and leadership have been instrumental in the timely development and commercialization of several mRNA-based vaccines and therapeutics. He is renowned for his strategic vision, market acumen, and ability to drive business results in emerging gene therapies modality market. 

Tadas holds a Bachelor of Science in Biology degree from Vilnius University and an Executive MBA from the Stockholm School of Economics. Currently residing and working in Uppsala, Sweden, Tadas continues to make impactful contributions to the field. His professional journey reflects a commitment to excellence and innovation, making him a notable figure among peers in the life sciences industry.